Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001756 · ClinicalTrials.gov registry record

Study of Mast Cell Precursors

A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
202
Enrollment target

NCT00001756 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 202 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001756 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
202 participants
Enrollment target

Study Summary

This study will investigate mast cell precursors that circulate in the blood. In a group of diseases collectively known as mastocytosis, mast cells accumulate in abnormal amounts in the skin, lymphoid tissues, bone marrow, liver and spleen. Some forms of mastocytosis have a generally good prognosis; for others, the prognosis is poorer. There is no known cure for any form of the disease. A better understanding of mast cells and how they respond to certain substances may provide insights that will lead to effective treatments for mastocytosis. Patients with systemic mastocytosis and normal healthy volunteers between the ages of 20 and 60 may be eligible for this 8-day study. Participants will undergo the following procedures: * Day 1 Medical history, physical examination, and blood tests to assess general health status * Days 2 through 6 Daily injections under the skin of G-CSF a hormone that stimulates white blood cell production * Day 7 Leukapheresis a procedure for collecting large numbers of white blood cells. In leukapheresis, blood is drawn through a needle placed in an arm and channeled into a cell separator machine. The white cells are collected and the rest of the blood is returned to the body through a needle in the other arm. The procedure takes up to 3 hours. * Days 7 and 8 Blood draw (about 1 teaspoon) to monitor white blood cell counts.

Trial Details

FieldValue
Enrollment Target 202 participants
Start Date 1997-12-03
Est. Completion 2022-11-03

What the Registry Record Tells You About NCT00001756

The ClinicalTrials.gov registry entry for NCT00001756 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00001756 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00001756 about?

NCT00001756 is a clinical study titled "Study of Mast Cell Precursors". This study will investigate mast cell precursors that circulate in the blood. In a group of diseases collectively known as mastocytosis, mast cells accumulate in abnormal amounts in the skin, lymphoid tissues, bone marrow, liver and spleen. Some forms of mastocytosis have a generally good prognosis;...

What is the current status of trial NCT00001756?

This trial is currently completed. The enrollment target is 202 participants. The study started on 1997-12-03. Estimated completion is 2022-11-03.

Who is sponsoring clinical trial NCT00001756?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.